 | |||||||
| news | |||||||
| NEWS | |||||||
The Interplay Key Decisions at the Intersection of Antitrust and Life Sciences - June 2024 The court also denied Teva's motion to dismiss antitrust counterclaims arising from those patent listings and allegations of sham patent litigation. Teva had sued Amneal for patent infringement after Amneal filed an Abbreviated New Drug Application (ANDA) ...
| |||||||
| See more results | Edit this alert | |||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment